All analyses

DaVita Inc. (DVA) Stock Analysis

Score B

Value · Grade D · Bullish

Healthcare · Medical Care Facilities

$196.03

Fair Value

$235.25

+20.0%

Conviction

7/10

Quality

D

Classification

Value

Investment Thesis

Price is above modeled value range. Quality supports holding but not attractive for new positions.

Appears undervalued but quality concerns keep the score lower.

For New Investors

Price above modeled value range

For Current Holders

Quantitative score: neutral

Buy if

  • Price drops 15-20% (improves asymmetry)
  • Bull scenario catalysts materialize
  • Market-wide correction creates opportunity

Sell if

  • Bear scenario triggers occur
  • Quality metrics deteriorate (ROIC declining)
  • Better alternatives emerge

Valuation

Fair Value estimate: $235.25 (+20.0%). Significantly undervalued.

PEG-Based EPS

$239.74

FCF DCF Model

$294.05

EV/EBITDA

$138.21

Blended Fair Value

$235.25

Confidence

Medium

Methods

PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA

Quality Analysis

D

59/120 points

Low Quality

ROE (3Y Avg)

6.4%

ROIC-WACC Spread

-1.7%

D/E Ratio

0.5x

Current Ratio

1.3x

Interest Coverage

4x

FCF Positive Years

3/3

Quality Flags

  • Low ROE: 6.4% (need >15%, got 3/20 pts)
  • ROIC spread: -1.7pp (got 0/25 pts)
  • Leverage: D/E 0.5x (11/15 pts)

Market Sentiment

Wall Street Consensus

$199.50

+1.8% Upside

7 analysts

Range: $190.00$220.00

Rating: Hold

Our model aligns with Wall Street consensus.

Trend & Technical

Bullish

Price ($195.77) is 44.3% above SMA 200 ($135.68). Bullish trend confirmed.

Technical Score80/100

Tech Score 80/100 — Strong technical setup. Trend, momentum, and positioning aligned bullish.

Risk & Reward

Asymmetry Ratio

2.65:1

Expected Return

+9.9%

Bull Upside

+37.1%

Bear Downside

-14.0%

Good asymmetry: 2.65:1 ratio. Upside justifies risk.

Verdict: Favorable

Scenario Analysis

Bear

Base

Bull

Buy Zone & Action Plan

See exact entry zones, stop-loss levels, and a personalized action plan.

Access free

AI Executive Summary

Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.

Access free

Technical Analysis

RSI, MACD, moving averages, trend signals, and momentum indicators.

Access free

Ask AI about this stock

Chat with our AI analyst to ask questions about valuation, risks, or comparisons.

Access free

Frequently Asked Questions

What is the fair value of DVA?

Based on our multi-method conviction analysis, the estimated fair value of DaVita Inc. (DVA) is $235.25. This is calculated by blending PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is medium.

Is DVA a buy, sell, or hold?

DVA currently has a HOLD rating with a conviction score of 7/10. Price is above modeled value range. Quality supports holding but not attractive for new positions. Price above modeled value range.

Is DVA a high-quality stock?

DaVita Inc. has a quality grade of D (59/120 points), rated as Low Quality. Key metrics include ROE of 6.4%, ROIC-WACC spread of -1.7%, and D/E ratio of 0.5x.

What type of stock is DVA?

DVA is classified as a "value" in our framework. Low dividend (reinvesting): 0.0%, High FCF Yield: 10.4%, Mature growth: 8.3%, Moderate growth: 8.3%, Market-like beta: 0.84

What do Wall Street analysts say about DVA?

7 Wall Street analysts have a consensus price target of $199.50 for DVA, representing +1.8% upside. Targets range from $190.00 to $220.00. The consensus recommendation is "Hold". Our model aligns with Wall Street consensus.

What are the risks of investing in DVA?

The risk/reward asymmetry ratio for DVA is 2.65:1, rated as Favorable. Good asymmetry: 2.65:1 ratio. Upside justifies risk. The expected return is +9.9%, with bull case upside of +37.1% and bear case downside of -14.0%.

What is the current trend for DVA?

DVA is in a bullish trend. Price ($195.77) is 44.3% above SMA 200 ($135.68). Bullish trend confirmed. The technical score is 80/100.

Related Stock Analyses

Best Stocks to Buy

Get the complete analysis

Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.

Last updated: May 19, 2026 · Framework version 3.7

This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.